Results 41 to 50 of about 70,305 (361)

Left ventricular assist devices: a kidney’s perspective [PDF]

Heart Failure Reviews, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Tromp, T R, de Jonge, N, Joles, J A
openaire   +4 more sources

Factors influencing transfusion-associated HLA sensitization in patients bridged to heart transplantation using ventricular assist device. [PDF]

, 2020
BackgroundBridging heart failure patients with mechanical ventricular assist devices (VAD) enables access to transplantation. However, VAD is associated with increased risk for anti-HLA antibodies associated with rejection of subsequent allografts ...
Adler, Eric, Elkind, Jae, Morris, Gerald P, Ostberg-Braun, Oscar, Silva Enciso, Jorge, Sobczyk, Juliana   +5 more
core   +1 more source

Stent implantation in a left ventricular assist device

REC: Interventional Cardiology (English Ed.), 2020
Sixty-eight-year-old male patient carrier of one HeartWare left ventricular assist device as destination therapy due to ischemic dilated cardiomyopathy.
Raquel Álvarez Ramos, Luis María Andrés Lalaguna, José Luis Díez Gil   +2 more
doaj   +1 more source

Left Ventricular Assist Devices Are Underutilized [PDF]

Circulation, 2011
Heart failure has become one of the fastest growing cardiovascular diagnoses, with estimates as high as 500 000 new cases per year.1,2 This growth is in part a result of the reductions in death from acute coronary syndromes, increased use of implantable cardioverter defibrillators, and improved survival with most cardiovascular interventions, which ...
openaire   +2 more sources

Cavopulmonary assist for the failing Fontan circulation: impact of ventricular function on mechanical support strategy [PDF]

, 2014
Mechanical circulatory support--either ventricular assist device (VAD, left-sided systemic support) or cavopulmonary assist device (CPAD, right-sided support)--has been suggested as treatment for Fontan failure.
Chen, Jun, Frankel, Steven C., Giridharan, Guruprasad A., Ising, Mickey, Koenig, Steven C., Rodefeld, Mark D., Sobieski, Michael A.   +6 more
core   +1 more source

The impact of Hnrnpl deficiency on transcriptional patterns of developing muscle cells

FEBS Open Bio, EarlyView.
We performed nanopore whole‐transcriptome sequencing comparing RNA from Hnrnpl‐knockdown versus control C2C12 myoblasts to investigate the contributions of Hnrnpl to muscle development. Our results indicate that Hnrnpl regulates the expression of genes involved with Notch signaling and skeletal muscle, particularly splicing patterns of specific muscle ...
Hannah R. Littel, Mekala Gunasekaran, Audrey L. Daugherty, Natalya M. Wells, Johnnie Turner, Christine C. Bruels, Christina A. Pacak, Isabelle Draper, Peter B. Kang   +8 more
wiley   +1 more source

Impact of preoperative versus postoperative dialysis on left ventricular assist device outcomes: An analysis from the Society of Thoracic Surgeons Interagency Registry for Mechanically Assisted Circulatory Support databaseCentral MessagePerspective

JTCVS Open, 2022
Objective: Chronic kidney disease and renal failure are common in patients being considered for left ventricular assist device support. We sought to evaluate the outcomes of patients undergoing left ventricular assist device implantation with ...
J. Hunter Mehaffey, MD, MSc, Ryan Cantor, PhD, Susan Myers, MS, Nicholas R. Teman, MD, John A. Kern, MD, Gorav Ailawadi, MD, Francis Pagani, MD, James Kirklin, MD, Kenan Yount, MD, MBA, Leora Yarboro, MD   +9 more
doaj   +1 more source

The diagnosis of left ventricular assist device thrombosis [PDF]

Netherlands Heart Journal, 2015
The clinical course of a patient with a left ventricular assist device is described. A total of 6 weeks after device insertion, the lactate dehydrogenase (LDH) level increased to 2801 U/l despite adding low-molecular-weight heparin to acenocoumarol and aspirin. Pump thrombosis was suspected but unconfirmed by computed tomography.
Michiel Rienstra, Michiel E. Erasmus, Hendyke Gerds, Johan Brügemann   +3 more
openaire   +3 more sources

The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation [PDF]

, 2020
OBJECTIVE: The study objective was to investigate the progression of uncorrected mild aortic insufficiency and its impact on survival and functional status after left ventricular assist device implantation.
Damiano, Ralph J, Jr, Fischer, Irene, Itoh, Akinobu, Kotkar, Kunal, Masood, Muhammad F, Moon, Marc R, Nakajima, Tomohiro, Tanaka, Yuki, Wan, Fei   +8 more
core   +2 more sources

Long‐Term Temporal Profile of Motor Recovery After Intracerebral Hemorrhage

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Limited data is available to describe the temporal profile of long‐term recovery over 1 year after the stroke in patients with spontaneous intracerebral hemorrhage (ICH). Methods A registered multicentral cohort was conducted to consecutively include non‐herniated supratentorial ICH patients from November 2013 to January 2023 ...
Yan Zheng, Fu‐Xin Lin, Ling‐Yun Zhuo, Jian‐Cai Chen, Xin Ge, Xiang‐Lin Chen, Xue‐Jiao Wang, Zhi‐Gang Yao, You‐Liang Tong, Bo Xie, Bai‐Hai Guo, Zhao‐Sheng Sun, Zhi‐Hua Tian, Ping Qiu, Xin‐Ru Lin, Qiu He, Shu‐Na Huang, Ke Ma, Fang‐Yu Wang, Huang‐Cheng Shang‐Guan, Wen‐Hua Fang, Deng‐Liang Wang, Ying Fu, Yuan‐Xiang Lin, De‐Zhi Kang   +24 more
wiley   +1 more source